Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ezan

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Steroid Biochemistry and Molecular Biology|October 1, 1993
Enzyme immunoassay for nomegestrol acetate in human plasmaE Ezan, H Benech, R Bucourt, et al.
Journal of Immunoassay|November 14, 1997
An enzyme immunoassay for rat growth hormone: validation and application to the determination of plasma levels and in vitro releaseE Ezan, E Laplante, M T Bluet-Pajot, et al.
Journal of Cell Science|December 11, 1999
Source, catabolism and role of the tetrapeptide N-acetyl-ser-asp-lys-Pro within the testisJ Stéphan, N Melaine, E Ezan, et al.
Experimental Hematology|October 10, 1998
Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivoA Rousseau-Plasse, J Wdzieczak-Bakala, M Lenfant, et al.
Analytical Chemistry|July 1, 1993
Enzyme immunoassay using a rat prolactin-alkaline phosphatase recombinant tracerD Gillet, E Ezan, F Ducancel, et al.
The Journal of Clinical Investigation|February 1, 1996
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-prolineM Azizi, A Rousseau, E Ezan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1994
Pharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesisE Ezan, P Carde, J Le Kerneau, et al.
The Journal of Clinical Investigation|December 6, 2000
Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient miceJ Cole, D Ertoy, H Lin, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysisC Junot, M F Gonzales, E Ezan, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 10, 2009
Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapyH Chabre, B Gouyon, A Huet, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Steroid Biochemistry and Molecular Biology|October 1, 1993
Enzyme immunoassay for nomegestrol acetate in human plasmaE Ezan, H Benech, R Bucourt, et al.
Journal of Immunoassay|November 14, 1997
An enzyme immunoassay for rat growth hormone: validation and application to the determination of plasma levels and in vitro releaseE Ezan, E Laplante, M T Bluet-Pajot, et al.
Journal of Cell Science|December 11, 1999
Source, catabolism and role of the tetrapeptide N-acetyl-ser-asp-lys-Pro within the testisJ Stéphan, N Melaine, E Ezan, et al.
Experimental Hematology|October 10, 1998
Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivoA Rousseau-Plasse, J Wdzieczak-Bakala, M Lenfant, et al.
Analytical Chemistry|July 1, 1993
Enzyme immunoassay using a rat prolactin-alkaline phosphatase recombinant tracerD Gillet, E Ezan, F Ducancel, et al.
The Journal of Clinical Investigation|February 1, 1996
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-prolineM Azizi, A Rousseau, E Ezan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1994
Pharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesisE Ezan, P Carde, J Le Kerneau, et al.
The Journal of Clinical Investigation|December 6, 2000
Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient miceJ Cole, D Ertoy, H Lin, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysisC Junot, M F Gonzales, E Ezan, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 10, 2009
Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapyH Chabre, B Gouyon, A Huet, et al.
Pageof 5